Alpine Global Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,772
Closed -$1.23M 746
2021
Q4
$1.23M Buy
+16,772
New +$1.38M 0.18% 95

Other funds holding ASTH

Alpine Global Management's ASTH Position: Q1 2022 in Review

Alpine Global Management sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 16,772 shares — an estimated $1.23M sold.

Alpine Global Management first reported a position in ASTH in Q4 2021 and held it in 1 quarter. The position peaked at $1.23M in Q4 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • Alpine Global Management reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
  • Alpine Global Management sold 16,772 Astrana Health shares in Q1 2022, an estimated $1.23M.
  • Alpine Global Management first reported a position in Astrana Health in Q4 2021 and held it in 1 quarter.
  • Alpine Global Management's Astrana Health position peaked at $1.23M in Q4 2021.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on Alpine Global Management's 13F filing for Q1 2022, filed 13 May 2022.